NFSG
VRTX icon

Newbridge Financial Services Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Newbridge Financial Services Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97K Hold
10
– – ﹤0.01% 973
2026
Q1 		$4.46K Buy
+10
New +$4.66K ﹤0.01% 930
2025
Q3 		– Sell
-14
Closed -$6.23K – 1393
2025
Q2 		$6.23K Hold
14
– – ﹤0.01% 988
2025
Q1 		$6.79K Buy
+14
New +$6.52K ﹤0.01% 749
2024
Q4 		– Sell
-14
Closed -$6.51K – 1183
2024
Q3 		$6.51K Buy
+14
New +$6.72K ﹤0.01% 478
2024
Q1 		– Sell
-24
Closed -$9.77K – 1311
2023
Q4 		$9.77K Sell
24
-59
-71% -$21.8K ﹤0.01% 740
2023
Q3 		$28.9K Buy
83
+18
+28% +$6.29K 0.01% 558
2023
Q2 		$22.9K Hold
65
– – 0.01% 658
2023
Q1 		$20.5K Sell
65
-4
-6% -$1.2K 0.01% 713
2022
Q4 		$19.9K Hold
69
– – 0.01% 719
2022
Q3 		$20K Sell
69
-9
-12% -$2.59K 0.01% 700
2022
Q2 		$22K Sell
78
-70
-47% -$18.7K 0.01% 638
2022
Q1 		$39K Hold
148
– – 0.02% 543
2021
Q4 		$33K Hold
148
– – 0.02% 590
2021
Q3 		$27K Hold
148
– – 0.02% 585
2021
Q2 		$30K Sell
148
-36
-20% -$7.53K 0.02% 646
2021
Q1 		$40K Buy
184
+29
+19% +$6.37K 0.03% 452
2020
Q4 		$37K Sell
155
-288
-65% -$66.1K 0.03% 401
2020
Q3 		$121K Buy
+443
New +$122K 0.12% 177

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Newbridge Financial Services Group's VRTX Position: Q2 2026 in Review

Newbridge Financial Services Group held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 10 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Newbridge Financial Services Group first reported a position in VRTX in Q3 2020 and has held it in 19 quarters since. The position peaked at $121K in Q3 2020. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Newbridge Financial Services Group held 10 shares of Vertex Pharmaceuticals worth $4.97K as of Q2 2026.
  • Newbridge Financial Services Group left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #973 holding.
  • Newbridge Financial Services Group first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 19 quarters since.
  • Newbridge Financial Services Group's Vertex Pharmaceuticals position peaked at $121K in Q3 2020.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.